Drugs / Sbv
last change Feb 2020 re-read 2 minutes ago

Sbv

Developed for
cutaneous leishmaniasis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03023111 Comparator Jun 2017 → Aug 2019 cutaneous leishmaniasis Hospital Universitário Professor Edgard Santos Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Sbv ClinicalTrials.gov intervention name — accepted as the source's own label NCT03023111
Route Intravenous intravenously” NCT03023111